| Valeant Pharmaceuticals International | (NY: VRX) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(VRX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Stock Blog Hub,
5/16/13)
Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but including stock-based compensation expense) were short of the Zacks...(read more)
(market folly,
9/14/12)
We've seen past commentary from multiple managers on shares of Valeant Pharmaceuticals (VRX) and thought it was worth highlighting given that numerous respected managers own it.
Hedge Fund...(read more)
(ValueWalk.com,
9/4/12)
Valeant Pharmaceuticals Int (NYSE:VRX) (TSE:VRX) announced on Labor Day, a deal to acquire Medicis Pharmaceutical Corp (NYSE:MRX) in a $2.6 billion deal.
The Medicis...(read more)
Valeant Pharmaceuticals International (VRX) Company Overview
There is no analysis for VRX yet. But you can go to Wikinvest to help create one!
